Long ‐term efficacy, safety, and cumulative retention rate of antitumor necrosis factor‐alpha treatment for patients with Behcet's uveitis: A systematic review and meta‐analysis
ConclusionsAnti-TNF- α therapy represents an effective treatment for BU patients with favorable safety profile and high drug retention rate and a potential advantage of adalimumab over infliximab in terms of ocular inflammation remission, drug retention, and the incidence of severe infusion or injection reactions.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Xin Guan,
Zerui Zhao,
Miaomiao Xin,
Guangtao Xia,
Qingrui Yang,
Min Fu Tags: ORIGINAL ARTICLE Source Type: research
More News: Bacterial Pneumonia | Behcet's Disease | Databases & Libraries | Humira | Pneumonia | Remicade | Rheumatology | Science | Statistics | Study | Tuberculosis